TLDR
- Bitcoin mining costs to reach $37,856 after halving in April, according to CoinShares forecast.
- Injective has astounding upside potential and strong fundamentals as a blockchain platform for finance.
- NuggetRush is a new ICO that combines the best features of memes and utility.
After the recent SEC decision on Bitcoin ETF, all eyes are now on Bitcoin (BTC) halving. This event is expected to occur in April, a few months away. According to CoinShares’ estimate, the average production cost per BTC after halving will be $37,856 per BTC. This upcoming reduction in block rewards will threaten the profitability of many validators. On the good side, the value of BTC will likely soar after this event, making it one to anticipate.
Meanwhile, a growing trend in the crypto scene involves savvy investors doubling down on Injective (INJ) and NuggetRush (NUGX). Primed for explosive growth, these are the best cryptos to buy now.
NuggetRush (NUGX): Investor Favorite
NuggetRush (NUGX) has been hailed as one of the best meme coins to invest in. Its integration of utility gives it a competitive edge over other dog or cat coins without tangible applications. Hence, it is positioned as one of the meme coins with potential, making it a favorite among savvy investors.
If you are seeking a project that perfectly combines the best of memes and utility, NuggetRush should be your go-to. It stands at the intersection of play-to-earn (P2E), GameFi, and memes. Hence, as a P2E token, it will function as the in-game currency within the ecosystem. At the same time, the upcoming game will feature gold mining, with players set to enjoy a thrilling gameplay experience and earn valuable in-game assets.
Furthermore, as a memecoin, it is expected to skyrocket. In the fourth round of the presale, a token costs only $0.015, and experts predict a price jump of 50x in the first six months after its launch.
Bitcoin (BTC): Mining Cost to Reach $37,000 After Halving – CoinShares
Bitcoin (BTC) and its spot ETF offering recently got the green light from the US SEC, much to the excitement of the crypto community. The benefits of Bitcoin ETFs include the exposure of the asset to the wider financial landscape and its legitimization. It is worth noting that investing in BTC ETFs allows investors to gain direct exposure without holding the underlying asset.
Following the approval of spot Bitcoin ETFs by the SEC on January 10, the most anticipated event now is its halving, which is mere months away. According to a new report from CoinShares, the average production cost of 1 BTC is estimated at $37,856 after the halving. This upcoming reduction in Bitcoin block rewards will threaten the profitability of many validators. However, the silver lining is that the price of BTC will soar, positioning BTC as one of the best cryptos to invest in.
Injective (INJ): Upward March Continues
Injective (INJ) continues its upward march, showing no sign of stepping foot on the brakes anytime soon. This, along with its massive upside potential, makes it one of the best coins to invest in. Besides its staggering growth potential, investors have also been doubling down due to the critical role it plays in the crypto space.
As a layer-1 blockchain platform built for finance, Injective is fast becoming a popular name. It powers DeFi (decentralized finance) applications like decentralized spot and derivatives exchanges, as well as lending protocols and prediction markets, to name a few. With massive adoption anticipated, Injective is a promising play not to miss out on.
Conclusion
The Bitcoin halving—one of the most anticipated events—is expected to push up the average production cost of BTC to $37,856, according to CoinShares. Meanwhile, savvy investors are actively accumulating Injective and NuggetRush tokens, aiming to ride their strong bullish wave. To participate in the ongoing NUGX presale, click the link below.
Visit NuggetRush Presale Website
Disclaimer: The information provided is not trading advice, Bitcoinworld.co.in holds no liability for any investments made based on the information provided on this page. We strongly recommend independent research and/or consultation with a qualified professional before making any investment decisions.
